McDonald Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$624K Hold
678
0.15% 125
2025
Q4
$729K Sell
678
-406
-37% -$388K 0.23% 105
2025
Q3
$827K Buy
1,084
+395
+57% +$294K 0.25% 99
2025
Q2
$537K Sell
689
-381
-36% -$296K 0.13% 166
2025
Q1
$884K Sell
1,070
-10
-0.9% -$8.32K 0.23% 125
2024
Q4
$834K Sell
1,080
-30
-3% -$24.8K 0.21% 124
2024
Q3
$983K Sell
1,110
-50
-4% -$45K 0.25% 112
2024
Q2
$1.05M Sell
1,160
-2
-0.2% -$1.6K 0.28% 97
2024
Q1
$904K Buy
1,162
+7
+0.6% +$4.98K 0.25% 111
2023
Q4
$673K Hold
1,155
0.2% 130
2023
Q3
$620K Buy
1,155
+55
+5% +$28.3K 0.2% 130
2023
Q2
$516K Sell
1,100
-25
-2% -$10.5K 0.16% 151
2023
Q1
$386K Buy
1,125
+50
+5% +$16.9K 0.13% 168
2022
Q4
$393K Hold
1,075
0.13% 157
2022
Q3
$348K Sell
1,075
-50
-4% -$15.8K 0.13% 166
2022
Q2
$365K Hold
1,125
0.09% 211
2022
Q1
$322K Buy
1,125
+1,123
+56,150% +$289K 0.07% 248
2021
Q4
$552 Buy
+2
New +$507 ﹤0.01% 491

Other funds holding LLY

McDonald Partners's LLY Position: Q1 2026 in Review

McDonald Partners held its Eli Lilly (LLY) position steady in Q1 2026 at 678 shares worth $624K. The position accounts for 0.15% of the portfolio, ranked #125.

McDonald Partners first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.05M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • McDonald Partners held 678 shares of Eli Lilly worth $624K as of Q1 2026.
  • McDonald Partners left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.15% of McDonald Partners's portfolio in Q1 2026, its #125 holding.
  • McDonald Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • McDonald Partners's Eli Lilly position peaked at $1.05M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on McDonald Partners's 13F filing for Q1 2026, filed 15 May 2026.